<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362127">
  <stage>Registered</stage>
  <submitdate>20/02/2012</submitdate>
  <approvaldate>23/02/2012</approvaldate>
  <actrnumber>ACTRN12612000232831</actrnumber>
  <trial_identification>
    <studytitle>Relationship between calcium supplements and cardiovascular disease</studytitle>
    <scientifictitle>Acute effect of calcium supplementation on arterial stiffness and endothelial function in healthy volunteers aged 50 years and over</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Endothelial function</healthcondition>
    <healthcondition>Arterial stiffness</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Subjects will be studied immediately before (i.e on the same day) and 3 hours after 1000 mg calcium citrate orally (one dose)</interventions>
    <comparator>Baseline results</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Endothelial function assessed by ENDO-PAT 2000</outcome>
      <timepoint>Before and 3 hours after taking calcium supplement</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Arterial stiffness assessed by pulse wave analysis</outcome>
      <timepoint>Before and 3 hours after taking calcium supplement</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Age &gt; 50 years</inclusivecriteria>
    <inclusiveminage>50</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>100</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Taking calcium or vitamin D (&gt;300 IU/day) in the last 3 months
Taking proton pump inhibitors in last 3 months
Taking calcium channel blockers in the last 3 months 
Primary hyperparathyroidism
Diabetes mellitus
Atrial fibrillation
Raynauds phenomenon</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>Consenting subjects who meet inclusion and exclusion criteria are enrolled into a single open group.</concealment>
    <sequence>NA</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Safety</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>17/05/2011</anticipatedstartdate>
    <actualstartdate>17/05/2011</actualstartdate>
    <anticipatedenddate />
    <actualenddate>23/04/2012</actualenddate>
    <samplesize>25</samplesize>
    <actualsamplesize>25</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Morton Burt</primarysponsorname>
    <primarysponsoraddress>Southern Adelaide Diabetes and Endocrine Services
Repatriation General Hospital
Daws Rd
Daw Park SA 5041</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Foundation Daw Park</fundingname>
      <fundingaddress>Repatriation General Hospital
Daws Rd
Daw Park SA 5041</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Southern Adelaide Health Service</sponsorname>
      <sponsoraddress>Flinders Drive
Flinders Medical Centre
Bedford Park SA 5042</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Calcium supplements increase bone density and are frequently prescribed to patients with osteoporosis. However, it is not certain whether they reduce the risk of fracture. A recent study from Auckland, New Zealand raised the possibility that calcium supplements might increase the risk of a heart attack (1). Therefore the medical community is reassessing the pros and cons of taking calcium supplements.

After taking calcium tablets, the concentration of calcium in blood increases slightly for a few hours. The flow of calcium from blood into the muscle cells that line blood vessels causes them to contract. We hypothesize that the increase in blood calcium after taking calcium tablets makes the blood vessels contract and become stiffer, putting pressure on the heart. This study will assess the stiffness of blood vessels in 20 subjects before and after a single dose of calcium. We hope to determine whether arterial stiffening is a mechanism that could explain a relationship between calcium supplements and an increased risk of heart disease.

Reference
1. Bolland MJ, Barber PA, Doughty RN et al. BMJ 2008; 336:262-266</summary>
    <trialwebsite>Nil</trialwebsite>
    <publication>Burt MG, Mangelsdorf BL, Srivastava D, Petersons CJ. Acute effect of calcium citrate on serum calcium and cardiovascular function. J Bone Miner Res 2013;28:412-418</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Southern Adelaide Clinical Human Research Ethics Committee</ethicname>
      <ethicaddress>Flinders Drive
Flinders Medical Centre
Bedford Park SA 5042</ethicaddress>
      <ethicapprovaldate>18/04/2011</ethicapprovaldate>
      <hrec>1/11/0066</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Morton Burt</name>
      <address>Southern Adelaide Diabetes and Endocrine Services
Repatriation General Hospital
Daws Rd
Daw Park SA 5041</address>
      <phone>+61 8 82751094</phone>
      <fax>+61 8 82751215</fax>
      <email>morton.burt@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Morton Burt</name>
      <address>Southern Adelaide Diabetes and Endocrine Services
Repatriation General Hospital
Daws Rd
Daw Park SA 5041</address>
      <phone>+61 8 82751094</phone>
      <fax>+61 8 82751215</fax>
      <email>morton.burt@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Morton Burt</name>
      <address>Southern Adelaide Diabetes and Endocrine Services
Repatriation General Hospital
Daws Rd
Daw Park SA 5041</address>
      <phone>+61 8 82751094</phone>
      <fax>+61 8 82751215</fax>
      <email>morton.burt@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Morton Burt</name>
      <address>Southern Adelaide Diabetes and Endocrine Services
Repatriation General Hospital
Daws Rd 
Daw Park SA 5041</address>
      <phone>61882751094</phone>
      <fax />
      <email>morton.burt@sa.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>